DUBLIN, Feb. 22, 2024 /PRNewswire/ — The “Generative AI in Pharmaceutical Market Report: Trends, Forecast and Competitive Analysis to 2030” report has been added to ResearchAndMarkets.com’s offering.
In a latest comprehensive analysis, the global pharmaceutical industry is poised to witness a transformative growth trajectory through the integration of generative AI. As traditional drug discovery and clinical trial design evolve, generative AI emerges as a pivotal technological advancement, driving efficiency and innovation. Anticipated to flourish at an impressive CAGR of 29.5% from 2024 to 2030, this sector represents a frontier of unprecedented opportunities in clinical research and development.
Contributing factors to this remarkable growth include the burgeoning need for revolutionary drug discovery, the generation of synthetic data for clinical trials, and a heightened focus on patient-specific treatment plans. The advent of generative AI not only streamlines the identification and analysis of large patient datasets but also enhances the monitoring of drug safety and efficacy.
Groundbreaking Applications Spearhead Generative AI Integration
Generative AI is categorized into various segments, encompassing Small Molecule and Large Molecule types, and utilizes advanced technologies like Deep Learning and Natural Language Processing. Among these, Deep Learning stands out as the dominant technology segment, given its robust ability to discern patterns and synthesize insights from extensive datasets.
This is particularly significant in the drug discovery domain, which continues to secure the largest segment due to the vast analysis requirements of chemical structures and related data.
Geographically, North America is projected to maintain its lead in the market. The rise of chronic diseases coupled with the stronghold of major industry players in the region underscores North America’s pivotal role in the upward trend of generative AI within pharmaceuticals.
Small Molecule and Large Molecule by Type
Deep Learning, Natural Language Processing by Technology
Clinical Trial Research, Drug Discovery by Application
North America Leads Regional Market
Key players recognized for fueling innovation and shaping the competitive landscape include distinguished names such as Bayer, Insilico Medicine, Atomwise, BenevolentAI, and several others. These companies are trailblazers, investing in research and development, expanding their facilities, and leveraging technological integrations to meet the accelerating demands.
Unveiling Market Dynamics and Future Outlook
Experts outline the intricate market dynamics at play, delving into facets such as key challenges, competitive threats, customer demand shifts, and emerging trends. Critical strategic analysis such as merger and acquisition activities, and prominent developments spearheaded by industry leaders are crucial in understanding the market’s direction. As these innovators continue to launch novel products and intensify their foray into uncharted territories, the industry’s landscape is expected to reshape significantly in the coming years.
The report furnishes a host of insights revealing successful strategies, growth opportunities across diverse markets and types, and detailed segmentation analyses. It offers a lens into the industry’s potency based on Porter’s Five Forces model and illuminates the potential trajectory of the generative AI in the pharmaceutical sector. As the industry continues to surge into a new era, stakeholders eagerly anticipate the transformative outcomes promised by generative AI’s maturation and widespread adoption in the pharmaceutical domain.
Generative AI in Pharmaceutical by Segment
The study includes a forecast for generative AI in the global pharmaceutical by type, technology, application, and region.
Generative AI in Pharmaceutical Market by Type
Small Molecule
Large Molecule
Generative AI in Pharmaceutical Market by Technology
Deep Learning
Natural Language Processing
Querying Method
Context-Aware Processing
Others
Generative AI in Pharmaceutical Market by Application
Clinical Trial Research
Drug Discovery
Research and Development
Others
Companies Profiled
Bayer
Insilico Medicine
Atomwise
BenevolentAI
Numerate
XtalPi
Berg Health
For more information about this report visit https://www.researchandmarkets.com/r/qd2t5s
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo – https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets